May 22 |
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
|
May 22 |
Play These New ETFs to Tap Lucrative Weight Loss Drug Market
|
May 22 |
Australia to ban copycat versions of weight loss drugs like Ozempic
|
May 22 |
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
|
May 22 |
Eli Lilly’s mirikizumab shows promise in Phase III Crohn’s disease trial
|
May 22 |
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
|
May 22 |
Dow Jones Futures: Nasdaq Hits High, Eli Lilly Breaks Out, But Here Comes Nvidia
|
May 21 |
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
|
May 21 |
IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
|
May 21 |
If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
|